Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
暂无分享，去创建一个
Jakob Nikolas Kather | T. Luedde | J. Kather | S. Loosen | F. Tacke | T. Brümmendorf | C. Roderburg | V. Keitel | M. Vucur | M. Schulze-Hagen | F. Beier | A. Schneider | C. Koppe | M. Jördens | A. Mertens | Joao Gorgulho